Cell-penetrating peptides as transporters for morpholino oligomers: Effects of amino acid composition on intracellular delivery and cytotoxicity

Nucleic Acids Research

Volumn 35, Issue 15, 2007, Pages 5182-5191

  Wu, Rebecca P ^a   Youngblood, Derek S ^a   Hassinger, Jed N ^a   Lovejoy, Candace E ^a   Nelson, Michelle H ^a   Iversen, Patrick L ^a   Moulton, Hong M ^a  

^a AVI BIOPHARMA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO ACID; AMINOCAPROIC ACID; ANTISENSE OLIGONUCLEOTIDE; ARGININE; BETA ALANINE; CELL PENETRATING PEPTIDE; DEXTRO ARGININE; OLIGOMER; PHOSPHORODIAMIDATE MORPHOLINO OLIGOMER; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; AMINO ACID SUBSTITUTION; ANTISENSE THERAPY; ARTICLE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE INSERTION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; RNA SPLICING;

6-AMINOCAPROIC ACID; ARGININE; BETA-ALANINE; BIOLOGICAL TRANSPORT; CELL LINE; CELL SURVIVAL; CULTURE MEDIA; HEMOLYSIS; HUMANS; INDICATORS AND REAGENTS; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDES; PROPIDIUM; RNA SPLICING; STEREOISOMERISM; TETRAZOLIUM SALTS; THIAZOLES;

EID: 34548569135     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm478     Document Type: Article

References (21)

1. Summerton,J. (1999) Morpholino antisense oligomers: The case for an rnase h-independent structural type. Biochim. Biophys. Acta, 1489, 141-158.
2. Nielsen,P.E., Egholm,M., Berg,R.H. and Buchardt,O. (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science, 254, 1497-1500.
3. Moulton,H.M., Hase,M.C., Smith,K.M. and Iversen,P.L. (2003) Hiv tat peptide enhances cellular delivery of antisense morpholino oligomers. Antisense Nucleic Acid Drug. Dev., 13, 31-43.
4. Moulton,H.M., Nelson,M.H., Hatlevig,S.A., Reddy,M.T. and Iversen,P.L. (2004) Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides. Bioconjug. Chem., 15, 290-299.
5. Youngblood,D.S., Hatlevig,S.A., Hassinger,J.N., Iversen,P.L. and Moulton,H.M. (2007) Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells. Bioconjug. Chem., 18, 50-60.
6. Abes,S., Moulton,H.M., Clair,P., Prevot,P., Youngblood,D.S., Wu,R.P., Iversen,P.L. and Lebleu,B. (2006) Vectorization of morpholino oligomers by the (r-ahx-r)(4) peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Control Release, 116, 304-313.
7. Burrer,R., Neuman,B.W., Ting,J.P., Stein,D.A., Moulton,H.M., Iversen,P.L., Kuhn,P. and Buchmeier,M.J. (2007) Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models. J. Virol., 81, 5637-5648.
8. McClorey,G., Moulton,H.M., Iversen,P.L., Fletcher,S. and Wilton,S.D. (2006) Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of dmd. Gene. Ther. 13, 1373-1381.
9. McClorey,G., Fall,A.M., Moulton,H.M., Iversen,P.L., Rasko,J.E., Ryan,M., Fletcher,S. and Wilton,S.D. (2006) Induced dystrophin exon skipping in human muscle explants. Neuromuscul. Disord., 16, 583-590.
10. Fletcher,S., Honeyman,K., Fall,A.M., Harding,P.L., Johnsen,R.D., Steinhaus,J.P., Moulton,H.M., Iversen,P.L. and Wilton,S.D. (2007) Morpholino oligomer mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Molecular Therapy, 00 In press.
11. Deas,T.S., Binduga-Gajewska,I., Tilgner,M., Ren,P., Stein,D.A., Moulton,H.M., Iversen,P.L., Kauffman,E.B., Kramer,L.D. and Shi,P.Y. (2005) Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and rna replication. J. Virol., 79, 4599-4609.
12. Ge,Q., Pastey,M., Kobasa,D., Puthavathana,P., Lupfer,C., Bestwick,R.K., Iversen,P.L., Chen,J. and Stein,D.A. (2006) Inhibition of multiple subtypes of influenza a virus in cell cultures with morpholino oligomers. Antimicrob. Agents. Chemother, 50, 3724-3733.
13. Yuan,J., Stein,D.A., Lim,T., Qiu,D., Coughlin,S., Liu,Z., Wang,Y., Blouch,R., Moulton,H.M., Iversen,P.L. et al. (2006) Inhibition of coxsackievirus b3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site. J. Virol., 80, 11510-11519.
14. Kang,S.H., Cho,M.J. and Kole,R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: Implications and applications in functional assay development. Biochemistry, 37 6235-6239.
15. Summerton,J. and Weller,D. (1997) Morpholino antisense oligomers: Design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 7, 187-195.
16. Summerton, J. and Weller, D. (1991) Uncharged morpholino-based polymers having phosphorus containing chiral intersubunit linkage. Patent US-5185444.
17. Chan,W. and White,P.E. (2000) Fmoc solid phase peptide synthesis; A Practical Approach Oxford University Press, New York.
18. Fischer,D., Li,Y., Ahlemeyer,B., Krieglstein,J. and Kissel,T. (2003) In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials, 24, 1121-1131.
19. Richard,J.P., Melikov,K., Vives,E., Ramos,C., Verbeure,B., Gait,M.J., Chernomordik,L.V. and Lebleu,B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem., 278, 585-590.
20. Rothbard,J.B., Kreider,E., VanDeusen,C.L., Wright,L., Wylie,B.L. and Wender,P.A. (2002) Arginine-rich molecular transporters for drug delivery: Role of backbone spacing in cellular uptake. J. Med. Chem. 45, 3612-3618.
21. Wender,P.A., Mitchell,D.J., Pattabiraman,K., Pelkey,E.T., Steinman,L. and Rothbard,J.B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc. Natl Acad. Sci. USA, 97, 13003-13008.